Latent Autoimmune Diabetes in Adults
📧 Sign up to get email alerts when something new happens for Latent Autoimmune Diabetes in Adults.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Effects of Cofrogliptin on Beta-Cell Function in LADA Patients [NA]
An update on a clinical trial evaluating Cofrogliptin for beta-cell function in latent autoimmune diabetes in adults, which is not yet recru…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes [NA]
Completed clinical trial evaluating a digital exercise intervention for middle-aged adults with Type 1 diabetes and latent autoimmune diabet…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes [Phase 2]
Phase 2 study results for injections of glutamic acid decarboxylase (GAD) for latent autoimmune diabetes in adults (LADA) have been posted a…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Genetics of Latent Autoimmune Diabetes in Adults
This clinical trial update summarizes a completed study investigating the genetics of latent autoimmune diabetes in adults (LADA).
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult) [Phase 2]
Phase 2 trial evaluating the safety of Diamyd in adults with latent autoimmune diabetes in adults (LADA) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: Early Insulin Treatment in Patients With Latent Autoimmune Diabetes [Phase 4]
Phase 4 clinical trial assessing early insulin treatment in adults with latent autoimmune diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-19Clinical Trial Update: Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) [Phase 2]
Phase 2 trial evaluating multiple subcutaneous doses of DiaPep277 in latent autoimmune diabetes in adults assessed safety, tolerability, imm…